KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Pfizer (PFE) over the last 17 years, with Q2 2025 value amounting to $25.0 million.

  • Pfizer's Income towards Parent Company rose 4705.88% to $25.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 21363.64%. This contributed to the annual value of $11.0 million for FY2024, which is 17333.33% up from last year.
  • According to the latest figures from Q2 2025, Pfizer's Income towards Parent Company is $25.0 million, which was up 4705.88% from -$8.0 million recorded in Q3 2024.
  • Pfizer's Income towards Parent Company's 5-year high stood at $34.0 million during Q3 2022, with a 5-year trough of -$236.0 million in Q3 2021.
  • Moreover, its 5-year median value for Income towards Parent Company was -$3.5 million (2023), whereas its average is -$16.4 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first crashed by 100000.0% in 2022, then skyrocketed by 95000.0% in 2024.
  • Over the past 5 years, Pfizer's Income towards Parent Company (Quarter) stood at -$13.0 million in 2021, then crashed by 61.54% to -$21.0 million in 2022, then decreased by 23.81% to -$26.0 million in 2023, then skyrocketed by 69.23% to -$8.0 million in 2024, then skyrocketed by 412.5% to $25.0 million in 2025.
  • Its Income towards Parent Company was $25.0 million in Q2 2025, compared to -$8.0 million in Q3 2024 and $17.0 million in Q2 2024.